Morgan Stanley (MS)

The second phase of the Q4 earnings season officially moves into high gear this Tuesday, February 10, 2026, as a critical cohort of financial institutions and market infrastructure giants prepare to release their results. While the initial wave of money-center banks in January provided a glimpse into corporate health, this

This household name has joined rarified company with a 13-figure valuation.

In special recognition of the Go Red for Women® campaign, Morgan Stanley Wealth Management will collaborate with the American Heart Association in Westchester and Fairfield Counties, to host the 17th Annual Go Red Women’s Leadership event on Friday, February 6 at 8:00 a.m. EST at Morgan Stanley’s Purchase, NY offices. The event will also be live streamed.

Archer-Daniels-Midland has notably outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.

Despite American Electric Power's outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

Cardinal Health has outperformed the broader market over the past year, and analysts remain highly optimistic about the stock’s prospects.

Wall Street’s updated price targets on Amgen imply a wide range from about 16% downside to a 15% upside from the stock’s last close.

Reddit heads into Q4 earnings with its RSI near 21 and shares down 29% over the past year.

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.

Oracle stock continued to drop in January.

WDC is highly leveraged to the AI boom.

Shares of hotel and casino entertainment company Caesars Entertainment (NASDAQ:CZR) jumped 8% in the afternoon session after the company announced the launch of the second phase of a $200 million transformation of its Caesars Republic Lake Tahoe Hotel & Casino. 

These industry leaders offer a compelling combination of growth and value.

Synchrony Financial has underperformed the S&P 500 Index over the past year, yet analysts remain moderately optimistic about the stock’s prospects.

Morgan Stanley (NYSE: MS) today is hosting its annual global Inclusive & Sustainable Ventures (MSISV) Demo Day, with startups and nonprofits participating from across the Americas, Europe, the Middle East and Africa (EMEA). The organizations will pitch over 300 investors, as well as potential business partners and customers.

Despite CenterPoint Energy's outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

This pre-revenue biopharmaceutical stock is a home run swing worth taking.

Shares of personal computing and printing company HP (NYSE:HPQ) fell 5.5% in the morning session after the company announced the immediate resignation of its CEO, Enrique Lores, which was followed by downgrades from several investment banks. Lores stepped down from his role as President, CEO, and board member to become the new chief executive at PayPal. In response to the leadership change, both Barclays and Goldman Sachs downgraded HP's stock. Barclays lowered its rating to "Underweight," while Goldman Sachs moved its rating to "Sell." Analysts cited ongoing challenges in the personal computer and printing markets, along with concerns over pressure on profit margins and demand. The company appointed board member Bruce Broussard as the interim CEO. Despite the abrupt change in leadership, HP stated that it maintained its earnings outlook for the upcoming quarters.

Sandisk has significantly outperformed the broader market this year, and analysts are cautiously optimistic about the stock’s prospects.

Investment banking firm PJT Partners (NYSE:PJT) fell short of the markets revenue expectations in Q4 CY2025, but sales rose 12.1% year on year to $535.2 million. Its non-GAAP profit of $2.55 per share was 6.4% above analysts’ consensus estimates.

The firm’s review suggests the challenges impacting Affirm are likely temporary and should ease over time.

With Conagra Brands trailing the broader market over the past year, Wall Street analysts remain cautious about the company’s near-term outlook and growth prospects.

Select Wall Street analysts think shares of Datadog and Atlassian are headed much higher in the next year.